Lung EC-SOD Overexpression Prevents Hypoxia-Induced Platelet Activation and Lung Platelet Accumulation
Antioxidants · 10.08.2024 · 13 (8) · 975
DOI: 10.3390/antiox13080975 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 10.08.2024. Verfasst von Daniel Colon Hidalgo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary and Critical Care, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, American Heart Association.
Abstract (Originalsprache)
Pulmonary hypertension (PH) is a progressive disease marked by pulmonary vascular remodeling and right ventricular failure. Inflammation and oxidative stress are critical in PH pathogenesis, with early pulmonary vascular inflammation preceding vascular remodeling. Extracellular superoxide dismutase (EC-SOD), a key vascular antioxidant enzyme, mitigates oxidative stress and protects against inflammation and fibrosis in diverse lung and vascular disease models. This study utilizes a murine hypobaric hypoxia model to investigate the role of lung EC-SOD on hypoxia-induced platelet activation and platelet lung accumulation, a critical factor in PH-related inflammation. We found that lung EC-SOD overexpression blocked hypoxia-induced platelet activation and platelet accumulation in the lung. Though lung EC-SOD overexpression increased lung EC-SOD content, it did not impact plasma extracellular SOD activity. However, ex vivo, exogenous extracellular SOD treatment specifically blunted convulxin-induced platelet activation but did not blunt platelet activation with thrombin or ADP. Our data identify platelets as a novel target of EC-SOD in response to hypoxia, providing a foundation to advance the understanding of dysregulated redox signaling and platelet activation in PH and other chronic hypoxic lung diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Pulmonary and Critical Care, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Cardiovascular Pulmonary Research Group, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Department of Pediatrics, Division of Neonatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Department of Pediatrics, Division of Critical Care, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
ORCID-Profile: Daniel Colon Hidalgo, Janelle N Posey, Samuel D Burciaga, Thi-Tina N Nguyen, Caitlin V Lewis, Eva S Nozik
Förderung
- NHLBI NIH HHS
- NIH HHS
- American Heart Association
- NICHD NIH HHS
- NIH/NHLBI/1F32HL167572-01A1 (DCH)
- NIH/NICHD/K12HD047349(CS)
- American Heart Association CDA
- NIH/NHLBI/1P01HL152961(CD)
Zitieren
APA
Colon Hidalgo, D., Jordan, M., Posey, J. N., Burciaga, S. D., Nguyen, T. N., Sul, C., Lewis, C. V., Delaney, C., & Nozik, E. S. (2024). Lung EC-SOD Overexpression Prevents Hypoxia-Induced Platelet Activation and Lung Platelet Accumulation. Antioxidants, 13(8), 975. https://doi.org/10.3390/antiox13080975
Vancouver
Colon Hidalgo D, Jordan M, Posey JN, Burciaga SD, Nguyen TN, Sul C, et al. Lung EC-SOD Overexpression Prevents Hypoxia-Induced Platelet Activation and Lung Platelet Accumulation. Antioxidants. 2024;13(8):975. doi:10.3390/antiox13080975
BibTeX
@article{ColonHidalgo2024,
author = {Colon Hidalgo, Daniel and Jordan, Mariah and Posey, Janelle N and Burciaga, Samuel D and Nguyen, Thi-Tina N and Sul, Christina and Lewis, Caitlin V and Delaney, Cassidy and Nozik, Eva S},
title = {Lung EC-SOD Overexpression Prevents Hypoxia-Induced Platelet Activation and Lung Platelet Accumulation},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {8},
pages = {975},
doi = {10.3390/antiox13080975}
}
EUVIMED